Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Palmieri

Showing results (271-280 of 291) with videos related to

Pageof 30
Sort By:
The British Journal of Dermatology|November 22, 2007
Molecular alterations at chromosome 9p21 in melanocytic naevi and melanomaM C Sini, A Manca, A Cossu, et al.
European Review for Medical and Pharmacological Sciences|January 2, 2024
Efficacy of guided autofluorescence laser therapy in MRONJ: a systematic reviewG Dipalma, A D Inchingolo, F Piras, et al.
International Journal of Oncology|December 22, 1999
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative GroupV Lorusso, G Palmieri, A R Bianco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinomaM Colombino, A Cossu, A Manca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assayG Palmieri, P A Ascierto, A Cossu, et al.
British Journal of Cancer|May 11, 2006
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancerF Ciardiello, T Troiani, F Caputo, et al.
American Journal of Clinical Oncology|March 14, 1998
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effectsP Tagliaferri, C Barile, M Caraglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumorsD Serpico, A Trama, E R Haspinger, et al.
Oncogenesis|December 6, 2016
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humansL Che, B Fan, M G Pilo, et al.
Mucosal Immunology|May 10, 2012
Size and dynamics of mucosal and peripheral IL-17A+ T-cell pools in pediatric age, and their disturbance in celiac diseaseR La Scaleia, M Barba, G Di Nardo, et al.
Pageof 30

Showing results (271-280 of 291) with videos related to

Sort By:
Pageof 30
The British Journal of Dermatology|November 22, 2007
Molecular alterations at chromosome 9p21 in melanocytic naevi and melanomaM C Sini, A Manca, A Cossu, et al.
European Review for Medical and Pharmacological Sciences|January 2, 2024
Efficacy of guided autofluorescence laser therapy in MRONJ: a systematic reviewG Dipalma, A D Inchingolo, F Piras, et al.
International Journal of Oncology|December 22, 1999
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative GroupV Lorusso, G Palmieri, A R Bianco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinomaM Colombino, A Cossu, A Manca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assayG Palmieri, P A Ascierto, A Cossu, et al.
British Journal of Cancer|May 11, 2006
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancerF Ciardiello, T Troiani, F Caputo, et al.
American Journal of Clinical Oncology|March 14, 1998
Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effectsP Tagliaferri, C Barile, M Caraglia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumorsD Serpico, A Trama, E R Haspinger, et al.
Oncogenesis|December 6, 2016
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humansL Che, B Fan, M G Pilo, et al.
Mucosal Immunology|May 10, 2012
Size and dynamics of mucosal and peripheral IL-17A+ T-cell pools in pediatric age, and their disturbance in celiac diseaseR La Scaleia, M Barba, G Di Nardo, et al.
Pageof 30